Mylan NV shares slid 10 percent on Wednesday after the generic drug maker predicted poor 2019 earnings that led some Wall Street analysts to wonder if its finances would worsen further.
from Latest https://ift.tt/2EAGPIJ
from Latest https://ift.tt/2EAGPIJ
Comments
Post a Comment